Pharma Grade Synthetic Camphor Market
Market Insights on Pharma Grade Synthetic Camphor covering sales outlook, demand forecast & up-to-date key trends
Pharma Grade Synthetic Camphor Market by Product- By Formulation (Topical, Inhalation), By Application (Respiratory Disorders, Muscular Rheumatism, Counterirritant and Antipruritic, Others), By Distribution Channel (Conventional B2B, Online B2B), and by Region, forecast for 2022 - 2028
Pharma Grade Synthetic Camphor Market Snapshot
[253 Pages Report] Global Pharma Grade Synthetic Camphor Market is projected to register the growth of 4.2% CAGR from 2022 to 2028, with an estimated market value of around US$ 532.0 Mn in 2028.
Market Outlook:
|
Data Points |
Market Insights |
|
Pharma Grade Synthetic Camphor Market Value- Base Year 2021 |
US$ 398.3 Mn |
|
Pharma Grade Synthetic Camphor Market Value- Estimate Year 2022 |
US$ 415.4 Mn |
|
Pharma Grade Synthetic Camphor Market Value- Projected Year 2028 |
US$ 532.0 Mn |
|
CAGR 2022-2028 |
4.2% |
|
Share of top 5 Countries |
58.3% |
|
Key Players |
Merck KGaA, Oriental Aromatics Limited, Saptagir Camphor Limited, Mangalam Organics Limited, Nippon Fine Chemical Co., Ltd., Rochem International, Inc., Spectrum Chemical Mfg. Corp., Aldon Corporation, Prinova Group LLC., Fengchen Group Co., Ltd., and Others (100% Market Share) |
As per Future Market Insights’ projections, the topical product holds a substantial share of over 71.5% in 2021 in the overall pharma grade synthetic camphor market.
This surge in use of private labelled topical products containing camphor, increasing rate of self-medication among patients and availability of over-the-counter (OTC) drugs and economic growth is been expected to aid the recovery in certain commodity exports such as camphor.
The global upswing in the investment thus, enthusing the major recovery in mature markets is been witnessed as a critical market driver for the pharma grade synthetic camphor market. However, the shift of positive market sentiments in developing economies, partial recovery in commodity prices are the factors, which are aiding the growth of the market.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1, 2021 |
4.14% |
|
H1, 2022 Projected |
4.21% |
|
H1, 2022 Outlook |
4.11% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 10 ↓ |
|
BPS Change – H1, 2022 (O) – H1, 2021 |
(-) 3 ↓ |
The pharma grade synthetic camphor market is under influence of healthcare expenditure and innovation factors subject to macro and industry factors. Key developments in the market include expansion of manufacturing facilities and exporting products across the globe.
According to FMI analysis, the pharma grade synthetic camphor market will decline by 03 Basis Share Point (BPS) in H1-2022 against H1-2021. A comparison of H1-2022 Outlook and H1-2022 projected growth showed a declining growth with 10 BPS.
Variations in the price of raw materials used in the production of synthetic camphor, which caused many small-scale manufacturers to exit the market, have acted as a restraint on the market's expansion, leading towards a reduction in the BPS value for the pharma grade synthetic camphor market.
Additionally, some hindrances that stay ahead for the industry also include stringent regulatory restrictions for the usage of camphor in pharma grade products. Conversely, other market segments are expected to perform fairly and attain attractive growth prospects in the next half of projection period.
2016-2021 Pharma Grade Synthetic Camphor Demand Outlook Compared to 2022-2028 Forecast
The global pharma grade synthetic camphor market had witnessed a turnaround growth from 2016 onwards, the trend is been expected to continue over the forecast period, which will drive the demand for pharma-grade synthetic camphor. In addition, the incidence rate of several infectious disease is increasing globally. Indications such as respiratory diseases and sexually transmitted diseases are increasing at an alarming rate in countries across the globe.
Highly populated regions such as APAC, MEA and Latin America have high incidence and prevalence of infectious diseases, which in turn is increasing the demand for camphor containing treatment products for infectious disease. Also, surge in use of private labelled topical products containing camphor, which is been driven by positive consumer sentiment and growing demand for topical pain management products are the other factors which are driving the growth of the pharma-grade synthetic camphor market.
The global pharma grade synthetic camphor market constitutes nearly 4.4% of the US$ 9 Bn pharmaceutical excipients market globally in 2021. Private-labelled industry witnessing immense growth in the U.S. market, is been driven by positive consumer sentiment towards such products.
Hence, the demand outlook for pharma grade synthetic camphor market stands expected to grow rapidly during the forecast period from 2022- 2028. The pharma grade synthetic camphor market is expected to expand at a considerable growth rate of around CAGR 4.2%, and observe an incremental $ opportunity of USD 116.6 Mn from 2022 to 2028.
What are the Key Opportunities for Market Players?
With increasing diseases burden of influenza, the existing cases occurrence owing to the pandemic and market penetration of the players to increase the product accessibility are the factors that are contributing to the growth of the pharma grade synthetic camphor market.
For meeting the increasing demand, the key players are developing new products and expansions both, geographically and by enhancing their product portfolio.
- For instance, In April 2018, Rochem announced a strategic partnership with Changzhou Sunlight Pharmaceutical Co., Ltd. (Sunlight) for new product development and explore finished products in the China market.
- In Dec 2017, Spectrum Pharmacy Products signed an agreement with Federation of Pharmacy Networks to provide its products at discounted rates.
Thus, it offers a great opportunity to the manufacturers of the pharma grade synthetic camphor during the forecast years.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are the key challenges to pharma grade synthetic camphor Market?
The Raw material cost makes up approximately 34–40% of the camphor cost and thus access to high quality raw material at stable prices form a very important aspect of business success
Thus, growing prices of raw materials, i.e., alpha pinene or turpentine oil is a major challenge for the manufacturers of pharma grade synthetic camphor. Fluctuation in the exchange rates is expected to adversely affect the business and hamper the growth of the pharma grade synthetic camphor market. Additionally, regulatory restrictions for use of camphor in pharmaceutical products due to its restricted usage in analgesics will also impede the growth of the market in other product segments.
What is the Impact of the COVID-19 Crisis on the Market?
The COVID-19 outbreak initially affected the pharma grade synthetic camphor market negatively due to the lockdowns imposed in the first half of 2020, which resulted in disruption of the supply chain. While after the upliftment of the lockdown, as a prevention measure to avoid contracting the disease, the upward sale of the over the counter topical formulation products have been registered and trend of stocking of the products were also noted in the market owing to the disease COVID-19.
After facing series of challenges such as supply chain disruption, demand fluctuations and other pressing concerns during 2020, the companies are reviewing their long-term strategies to develop adequate crisis-management strategies that place a premium on next-generation products and solutions pharma grade synthetic camphor.
The R&D funding are being reduced modestly, market trends for pharma grade synthetic camphor are constantly being monitored and companies are also launching marketing initiatives with care, as well as long-term contracts are being strengthened to emerge stronger in the post-COVID pandemic scenario.
However, with the opening of all the economies and the people now adapting to the new normal, the pharma grade synthetic camphor market is been expected to achieve significant growth during the forecast period.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Country-wise Insights
Will the U.S. Remain a Key market for Pharma Grade Synthetic Camphor?
The U.S. is the leading country of the North American region with a total market share of 93.6% in 2021 and projected to continue commanding the high growth during the coming years from 2022- 2028 in pharma grade synthetic camphor market owing to its due to high value and high margins in the market. The growing practice of self-medication with OTC products, increased awareness among the masses for alternative medicine for general flu (symptomatic influenza) and related diseases is set to drive the market during the forecast period.
For instance, as per Centre for Disease Control, the annual incidence of flu cases in the U.S. was 35 million, leading to 380,000 hospital admissions during 2019-2020 year.
Why is Germany Considered a More Lucrative Market within Europe?
In the year 2021, Germany dominates the European market of pharma grade synthetic camphor, with a share of over 23.6% throughout the forecast period owing to the increasing demand of pharma-grade synthetic camphor. According to the World Health Organization (WHO), In Germany, yearly influenza epidemics lead to serious disease and death in high-risk populations. A 30–40 % rate of all influenza cases reported yearly is accounted to occur in the children.
The presence of efficient healthcare infrastructure and the key players in the country are supporting the growth of pharma grade synthetic camphor market growth.
Why is India an Emerging Market for Pharma Grade Synthetic Camphor?
India holds over 55% revenue share in the global market in the year 2021, and projected to expand at a CAGR of 5.4% during the forecast period of 2022-2028. It is been reported that, during 2018-19, Influenza infection in India was estimated as 132 per 1000 child-years. The patient’s positive for influenza in outpatients and inpatients were estimated to be 11.2% and 7.1% (respectively. A total influenza cases during 2018 as 16,009,207 in India. Influenza accounted for 10,913,476 outpatient visits and 1, 09,431 hospitalizations. The high incidence of the disease and deeper penetration of the key players and market accessibility of the products is aiding the growth of pharma grade synthetic camphor market.
What is the Outlook in China for the Pharma Grade Synthetic Camphor?
In 2021, China has considerable share in the global pharma grade synthetic camphor market of around 13.1% share by value and is projected to expand at a CAGR of 6.1% from 2022-2028. This is predominantly due to the rising number of influenza cases, for instance, as per the recent estimates, influenza-associated mortality rate was found the highest among adults aged ≥ 65 years, the highest influenza disease burden found among people aged ≥ 65 years and < 5 years in China, while the vaccination coverage in the Chinese population was only approximately 2%.
Furthermore, the miniscule penetration of vaccination among the target population poses the risk of infection transmissibility; hence in turn supporting the demand for pharma grade synthetic camphor in the market.
Category-wise Insights
Which Pharma Grade Synthetic Camphor Formulation is driving the market growth?
By Formulation type, the topical segment accounts for more than 70% market and is expected to expand at a CAGR of 4.4% during the forecast period from 2022 - 2028.
The topical Product benefits brings direct application on the skin, hence promoting greater absorption, relief from the nasal irritation, reduced side effects and toxicity to other organs and imparting soothing effect. Owing to its natural benefits, it will continue to be the most preferred product among the patients and resulting in growth of pharma grade synthetic camphor market during the forecast period of 2022-2028.
Why does the Respiratory Disorders hold a High Market Share?
The applications of pharma grade synthetic camphor in treating respiratory disorders is highly preferred and records the share of around 28.6% of the global revenue share in 2021. This trend is expected to continue to grow during the study period. The high share of this segment is attributable to the influenza cases, which affects the respiratory channels of the patients, hence promoting the usage of the synthetic camphor enabled products to be administered in the respiratory cases
Which Distribution Channel is leading the Global Pharma Grade Synthetic Camphor Market?
Based on the distribution channel, conventional B2B is the leading segment, with nearly 86.5% market share in 2021 due to its improved efficiency, improved awareness, enhanced analytics, and customer-centric experience. Additionally the patients choose OTC product purchases to be conducted at the pharmacies, hence, the significance of the mode of sale channel will maintain its relevancy in the forecast period of 2022-2028 and support the growth of pharma grade synthetic camphor market growth.
Competitive Landscape
The growing share of over the counter purchase and increasing availability of the products at multiple sales channels are the key strategies adopted by manufacturers and integrators for increasing the consumer base in different geographies.
Additionally, Key players are focusing on expansion of their brands and technology in emerging regions by strategic partnerships, and collaborations to strengthen their market presence.
For instance,
- In Jan 2017, Merck completed the acquisition of BioControl Systems Inc. to strengthen its position in food safety testing.
- In Aug 2016, Merck opened a new pharmaceuticals manufacturing plant in Nantong, China. These strategic investments further support Merck's expansion in China
Scope of the Report
|
Attribute |
Details |
|
Forecast Period |
2022-2028 |
|
Historical Data Available for |
2013-2021 |
|
Market Analysis |
USD Million for Value, Units for Volume |
|
Key Countries Covered |
U.S., China, India, Japan, Brazil, Germany, France, U.K., Mexico, South Africa, Italy, Canada, Argentina, Australia & NZ, Spain South Korea, India, ASEAN, Australia, New Zealand, South Africa, and GCC Countries |
|
Key Segments Covered |
Formulation type, applications, distribution channel and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Pharma Grade Synthetic Camphor Market Segmentation - by Category
By Formulation Type:
- Topical
- Inhalation
By Application:
- Respiratory Disorders
- Muscular Rheumatism
- Counterirritant and Antipruritic
- Others
By Distribution Channels:
- Conventional B2B
- Tenders
- Direct Procurement
- Wholesalers & Distributors
- Online B2B
- Internal Channel
- External Channel
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- APECJ
- Japan
- China
- Middle East & Africa
Frequently Asked Questions
How much is the market for Pharma Grade Synthetic Camphor worth?
The pharma grade synthetic camphor market is worth at US$ 398.3 Mn in the year 2021 and expected to reach US$ 532.0 Mn by 2028.
What is the demand outlook of the Pharma Grade Synthetic Camphor Market?
Pharma Grade Synthetic Camphor is projected to reflect high demand in the forecast period with a CAGR of 4.2%.
What are the key trends of Pharma Grade Synthetic Camphor?
Increasing burden of influenza in both developed and developing countries, increasing role of emerging markets of Latin America, APECJ and China as a leader in global production capacity for pharma-grade synthetic camphor are some of the key trends that will fuel the demand for pharma grade synthetic camphor.
What factors are driving demand for Pharma Grade Synthetic Camphor?
Rising adoption of pharma grade synthetic camphor products in abatement of respiratory disorders, and increase in the number of incidence of influenza cases are the major driving factors.
What is the market share of the top 5 countries in the Pharma Grade Synthetic Camphor market?
The cumulative market share of the top players constitutes nearly 58.3% of the overall global market share.
What are the top 5 countries driving demand for Pharma Grade Synthetic Camphor?
U.S., China, India, Japan and Brazil are the top 5 countries which are driving the demand for Pharma Grade Synthetic Camphor.
At what rate is the sales of Pharma Grade Synthetic Camphor rising in Western Europe?
Western Europe’s market is forecasted to grow at a CAGR of 3.1% between 2022- 2028. Germany being dominant country in term of revenue in European market of pharma grade synthetic camphor.
At what rate are Pharma Grade Synthetic Camphor going to register growth in Asia Pacific?
The Asia Pacific market is set to exhibit a CAGR of over 4.6% during the forecast period.
Which companies are key producers of Pharma Grade Synthetic Camphor?
Merck KGaA, Oriental Aromatics Limited, Saptagir Camphor Limited, Mangalam Organics Limited, Nippon Fine Chemical Co., Ltd., Rochem International, Inc., Spectrum Chemical Mfg. Corp., Aldon Corporation, Prinova Group LLC, and Fengchen Group Co., Ltd. are the key producers in this market.
Table of Content
1. Executive Summary 1.1. Market Overview 1.2. Market Analysis 1.3. FMI Analysis and Recommendations 1.4. Wheel of Fortune 2. Market Introduction 2.1. Market Taxonomy 2.2. Market Definition 3. Market Background 3.1. Macroeconomic Factors 3.2. Market Dynamics 3.2.1. Drivers 3.2.2. Restraints 3.2.3. Trends 3.2.4. Opportunity Analysis 3.3. Macroeconomic Assumptions 3.4. Global Economic Outlook 4. Key Inclusion 4.1. Global Synthetic Camphor Market Analysis 4.2. Regulatory Scenario 4.3. Pricing Analysis, By Region (2021A & 2028F) 5. North America Pharma-Grade Synthetic Camphor Market Analysis 2013-2021 and Forecast 2022-2028 5.1. Introduction 5.2. Historical Market Size (US$ Mn) and Volume (MT) Analysis By Country, 2013-2021 5.2.1. U.S. 5.2.2. Canada 5.3. Market Size (US$ Mn) and Volume (MT) Forecast By Country, 2022-2028 5.4. Historical Market Size (US$ Mn) Trend Analysis By Formulation Type, 2013-2021 5.4.1. Topical 5.4.2. Inhalation 5.5. Market Size (US$ Mn) Forecast By Formulation Type, 2022-2028 5.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 5.6.1. Respiratory Disorders 5.6.2. Muscular Rheumatism 5.6.3. Counterirritant and Antipruritic 5.6.4. Others 5.7. Market Size (US$ Mn) Forecast By Application, 2022-2028 5.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2021 5.8.1. Conventional B2B 5.8.1.1. Tenders 5.8.1.2. Direct Procurement 5.8.1.3. Wholesalers & Distributors 5.8.2. Online B2B 5.8.2.1. Internal Channel 5.8.2.2. External Channel 5.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 5.10. Market Attractiveness Analysis 5.10.1. By Country 5.10.2. By Formulation Type 5.10.3. By Application 5.10.4. By Distribution Channel 6. Latin America Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028 6.1. Introduction 6.2. Historical Market Size (US$ Mn) and Volume (MT) Analysis By Country, 2013-2021 6.2.1. Brazil 6.2.2. Mexico 6.2.3. Rest of Latin America 6.3. Market Size (US$ Mn) and Volume (MT) Forecast By Country, 2022-2028 6.4. Historical Market Size (US$ Mn) Trend Analysis By Formulation Type, 2013-2021 6.4.1. Topical 6.4.2. Inhalation 6.5. Market Size (US$ Mn) Forecast By Formulation Type, 2022-2028 6.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 6.6.1. Respiratory Disorders 6.6.2. Muscular Rheumatism 6.6.3. Counterirritant and Antipruritic 6.6.4. Others 6.7. Market Size (US$ Mn) Forecast By Application, 2022-2028 6.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2021 6.8.1. Conventional B2B 6.8.1.1. Tenders 6.8.1.2. Direct Procurement 6.8.1.3. Wholesalers & Distributors 6.8.2. Online B2B 6.8.2.1. Internal Channel 6.8.2.2. External Channel 6.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 6.10. Market Attractiveness Analysis 6.10.1. By Country 6.10.2. By Formulation Type 6.10.3. By Application 6.10.4. By Distribution Channel 7. Western Europe Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028 7.1. Introduction 7.2. Historical Market Size (US$ Mn) and Volume (MT) Analysis By Country, 2013-2021 7.2.1. Germany 7.2.2. France 7.2.3. U.K. 7.2.4. Spain 7.2.5. Italy 7.2.6. Rest of Western Europe 7.3. Market Size (US$ Mn) and Volume (MT) Forecast By Country, 2022-2028 7.4. Historical Market Size (US$ Mn) Trend Analysis By Formulation Type, 2013-2021 7.4.1. Topical 7.4.2. Inhalation 7.5. Market Size (US$ Mn) Forecast By Formulation Type, 2022-2028 7.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 7.6.1. Respiratory Disorders 7.6.2. Muscular Rheumatism 7.6.3. Counterirritant and Antipruritic 7.6.4. Others 7.7. Market Size (US$ Mn) Forecast By Application, 2022-2028 7.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2021 7.8.1. Conventional B2B 7.8.1.1. Tenders 7.8.1.2. Direct Procurement 7.8.1.3. Wholesalers & Distributors 7.8.2. Online B2B 7.8.2.1. Internal Channel 7.8.2.2. External Channel 7.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 7.10. Market Attractiveness Analysis 7.10.1. By Country 7.10.2. By Formulation Type 7.10.3. By Application 7.10.4. By Distribution Channel 8. Eastern Europe Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028 8.1. Introduction 8.2. Historical Market Size (US$ Mn) and Volume (MT) Analysis By Country, 2013-2021 8.2.1. Russia 8.2.2. Poland 8.2.3. Rest of Eastern Europe 8.3. Market Size (US$ Mn) and Volume (MT) Forecast By Country, 2022-2028 8.4. Historical Market Size (US$ Mn) Trend Analysis By Formulation Type, 2013-2021 8.4.1. Topical 8.4.2. Inhalation 8.5. Market Size (US$ Mn) Forecast By Formulation Type, 2022-2028 8.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 8.6.1. Respiratory Disorders 8.6.2. Muscular Rheumatism 8.6.3. Counterirritant and Antipruritic 8.6.4. Others 8.7. Market Size (US$ Mn) Forecast By Application, 2022-2028 8.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2021 8.8.1. Conventional B2B 8.8.1.1. Tenders 8.8.1.2. Direct Procurement 8.8.1.3. Wholesalers & Distributors 8.8.2. Online B2B 8.8.2.1. Internal Channel 8.8.2.2. External Channel 8.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 8.10. Market Attractiveness Analysis 8.10.1. By Country 8.10.2. By Formulation Type 8.10.3. By Application 8.10.4. By Distribution Channel 9. Asia Pacific excluding China & Japan (APECJ) Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028 9.1. Introduction 9.2. Historical Market Size (US$ Mn) and Volume (MT) Analysis By Country, 2013-2021 9.2.1. India 9.2.2. Australia and New Zealand 9.2.3. ASEAN 9.2.4. Rest of APEJ 9.3. Market Size (US$ Mn) and Volume (MT) Forecast By Country, 2022-2028 9.4. Market Size (US$ Mn) and Volume (MT) Forecast By Country, 2022-2028 9.5. Historical Market Size (US$ Mn) Trend Analysis By Formulation Type, 2013-2021 9.5.1. Topical 9.5.2. Inhalation 9.6. Market Size (US$ Mn) Forecast By Formulation Type, 2022-2028 9.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 9.7.1. Respiratory Disorders 9.7.2. Muscular Rheumatism 9.7.3. Counterirritant and Antipruritic 9.7.4. Others 9.8. Market Size (US$ Mn) Forecast By Application, 2022-2028 9.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2021 9.9.1. Conventional B2B 9.9.1.1. Tenders 9.9.1.2. Direct Procurement 9.9.1.3. Wholesalers & Distributors 9.9.2. Online B2B 9.9.2.1. Internal Channel 9.9.2.2. External Channel 9.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 9.11. Market Attractiveness Analysis 9.11.1. By Country 9.11.2. By Formulation Type 9.11.3. By Application 9.11.4. By Distribution Channel 10. Japan Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028 10.1. Introduction 10.2. Historical Market Size (US$ Mn) Trend Analysis By Formulation Type, 2013-2021 10.2.1. Topical 10.2.2. Inhalation 10.3. Market Size (US$ Mn) Forecast By Formulation Type, 2022-2028 10.4. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 10.4.1. Respiratory Disorders 10.4.2. Muscular Rheumatism 10.4.3. Counterirritant and Antipruritic 10.4.4. Others 10.5. Market Size (US$ Mn) Forecast By Application, 2022-2028 10.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2021 10.6.1. Conventional B2B 10.6.1.1. Tenders 10.6.1.2. Direct Procurement 10.6.1.3. Wholesalers & Distributors 10.6.2. Online B2B 10.6.2.1. Internal Channel 10.6.2.2. External Channel 10.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 10.8. Market Attractiveness Analysis 10.8.1. By Formulation Type 10.8.2. By Application 10.8.3. By Distribution Channel 11. China Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Trend Analysis By Formulation Type, 2013-2021 11.2.1. Topical 11.2.2. Inhalation 11.3. Market Size (US$ Mn) Forecast By Formulation Type, 2022-2028 11.4. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 11.4.1. Respiratory Disorders 11.4.2. Muscular Rheumatism 11.4.3. Counterirritant and Antipruritic 11.4.4. Others 11.5. Market Size (US$ Mn) Forecast By Application, 2022-2028 11.6. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2021 11.6.1. Conventional B2B 11.6.1.1. Tenders 11.6.1.2. Direct Procurement 11.6.1.3. Wholesalers & Distributors 11.6.2. Online B2B 11.6.2.1. Internal Channel 11.6.2.2. External Channel 11.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 11.8. Market Attractiveness Analysis 11.8.1. By Formulation Type 11.8.2. By Application 11.8.3. By Distribution Channel 12. MEA Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028 12.1. Introduction 12.2. Historical Market Size (US$ Mn) and Volume (MT) Analysis By Country, 2013-2021 12.2.1. GCC Countries 12.2.2. South Africa 12.2.3. Rest of MEA 12.3. Market Size (US$ Mn) and Volume (MT) Forecast By Country, 2022-2028 12.4. Historical Market Size (US$ Mn) Trend Analysis By Formulation Type, 2013-2021 12.4.1. Topical 12.4.2. Inhalation 12.5. Market Size (US$ Mn) Forecast By Formulation Type, 2022-2028 12.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 12.6.1. Respiratory Disorders 12.6.2. Muscular Rheumatism 12.6.3. Counterirritant and Antipruritic 12.6.4. Others 12.7. Market Size (US$ Mn) Forecast By Application, 2022-2028 12.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2021 12.8.1. Conventional B2B 12.8.1.1. Tenders 12.8.1.2. Direct Procurement 12.8.1.3. Wholesalers & Distributors 12.8.2. Online B2B 12.8.2.1. Internal Channel 12.8.2.2. External Channel 12.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 12.10. Market Attractiveness Analysis 12.10.1. By Country 12.10.2. By Formulation Type 12.10.3. By Application 12.10.4. By Distribution Channel 13. Forecast Factors: Relevance and Impact 14. Competition Analysis 14.1. Competition Development Snapshot 14.2. Competition Dashboard 14.3. Company Deep Dive (Company Overview, Product portfolio, Strategy, Company Footprint) 14.3.1. Merck KGaA 14.3.2. Oriental Aromatics Limited 14.3.3. Saptagir Camphor Limited 14.3.4. Mangalam Organics Limited 14.3.5. Fengchen Group Co., Ltd. 14.3.6. Nippon Fine Chemical Co., Ltd. 14.3.7. Rochem International, Inc. 14.3.8. Spectrum Chemical Mfg. Corp. 14.3.9. Aldon Corporation 14.3.10. Prinova Group LLC. 15. Global Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028, By Region 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Mn) and Volume (MT) Analysis By Region, 2013-2021 15.2.1. North America 15.2.2. Western Europe 15.2.3. Eastern Europe 15.2.4. Latin America 15.2.5. Asia Pacific excluding Japan and China 15.2.6. Japan 15.2.7. China 15.2.8. Middle East and Africa 15.3. Market Size (US$ Mn) and Volume (MT) Forecast By Region, 2022-2028 15.4. Market Attractiveness Analysis By Region 16. Global Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028, By Formulation Type 16.1. Introduction 16.2. Historical Market Size (US$ Mn) and Trend Analysis By Formulation Type, 2013-2021 16.2.1. Topical 16.2.2. Inhalation 16.3. Market Size (US$ Mn) Forecast By Formulation Type, 2022-2028 16.4. Market Attractiveness Analysis By Formulation Type 17. Global Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028, By Application 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 17.2.1. Respiratory Disorder 17.2.2. Muscular Rheumatism 17.2.3. Counterirritant and Antipruritic 17.2.4. Others 17.3. Market Size (US$ Mn) Forecast By Application, 2022-2028 17.4. Market Attractiveness Analysis By Application 18. Global Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028, By Distribution Channel 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2021 18.2.1. Conventional B2B 18.2.1.1. Tenders 18.2.1.2. Direct Procurement 18.2.1.3. Wholesalers & Distributors 18.2.2. Online B2B 18.2.2.1. Internal Channel 18.2.2.2. External Channel 18.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028 18.4. Market Attractiveness Analysis By Distribution Channel 19. Global Pharma-Grade Synthetic Camphor Market Analysis 2013-2021and Forecast 2022-2028 19.1. Market Value Share Analysis 19.1.1. By Country 19.1.2. By Formulation Type 19.1.3. By Application 19.1.4. By Distribution Channel 19.2. Y-o-Y Growth Analysis 19.3. Absolute $ Opportunity 20. Assumptions and Acronyms Used 21. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Median per capita consumption (by volume in standard units) of medicine in non-hospital sector by country income category Table 02: North Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Country Table 03: North Pharma-grade Camphor Market Volume (MT) Analysis 2013-2021 and Forecast 2018-2028, By Country Table 04: North America Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Distribution Channel Table 05: North America Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Formulation Table 06: North America Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Application Table 07: Latin America Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Country Table 08: Latin America Pharma-grade Camphor Market Volume (MT) Analysis 2013-2021 and Forecast 2018-2028, By Country Table 09: Latin America Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Distribution Channel Table 10: Latin America Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Formulation Table 11: Latin America Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Application Table 12: Western Europe Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Country Table 13: Western Europe Pharma-grade Camphor Market Volume (MT) Analysis 2013-2021 and Forecast 2018-2028, By Country Table 14: Western Europe Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Distribution Channel Table 15: Western Europe Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Formulation Table 16: Western Europe Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Application Table 17: Eastern Europe Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Country Table 18: Eastern Europe Pharma-grade Camphor Market Volume (MT) Analysis 2013-2021 and Forecast 2018-2028, By Country Table 19: Eastern Europe Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Distribution Channel Table 20: Eastern Europe Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Formulation Table 21: Eastern Europe Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Application Table 22: APECJ Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Country Table 23: APECJ Pharma-grade Camphor Market Volume (MT) Analysis 2013-2021 and Forecast 2018-2028, By Country Table 24: APECJ Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Distribution Channel Table 25: APECJ Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Formulation Table 26: APECJ Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Application Table 27: Japan Pharma-grade Camphor Market Volume (MT) Analysis 2013-2021 and Forecast 2018-2028 Table 28: Japan Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Distribution Channel Table 29: Japan Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Formulation Table 30: Japan Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Application Table 31: China Pharma-grade Camphor Market Volume (MT) Analysis 2013-2021 and Forecast 2018-2028 Table 32: China Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Distribution Channel Table 33: China Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Formulation Table 34: China Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Application Table 35: MEA Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Country Table 36: MEA Pharma-grade Camphor Market Volume (MT) Analysis 2013-2021 and Forecast 2018-2028, By Country Table 37: MEA Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Distribution Channel Table 38: MEA Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Formulation Table 39: MEA Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Application Table 40: Global Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Region Table 41: Global Pharma-grade Camphor Market Volume (MT) Analysis 2013-2021 and Forecast 2018-2028, By Region Table 42: Global Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Formulation Table 43: MEA Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Application Table 44: MEA Pharma-grade Camphor Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2018-2028, By Distribution Channel
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Trends in Global Investment and Trade (1998–2021) Figure 02: Variation in Pharmaceutical Production Capacity Across the Globe Figure 03 : Global Healthcare Expenditure in US$ Tn (2013–2021) Figure 04: Global Synthetic Camphor Market and Share of Pharma-grade Camphor market (2021) Figure 05: Global Pharma-grade Camphor Market Price/Kg Analysis, By Region (2021) Figure 06: Global Pharma-grade Camphor Market Price/Kg Analysis, By Region (2028) Figure 07: North America Pharma-grade Camphor Market Value Analysis By Distribution Channel (2021 & 2028) Figure 08: North America Pharma-grade Camphor Market Value Share Analysis, by Application (2021) Figure 09: North America Pharma-grade Camphor Market Volume Share (%), By Country (2022 & 2028) Figure 10: North Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021, Figure 11: North Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 12: U.S. Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 13: U.S. Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 14: Canada Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 15: Canada Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 16: North America Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021, By Conventional B2B Figure 17: North America Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Conventional B2B Figure 18: North America Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021, By Online B2B Figure 19: North America Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Online B2B Figure 20: North America Pharma-grade Camphor Market Attractiveness Analysis, By Country Figure 21: North America Pharma-grade Camphor Market Attractiveness Analysis, By Formulation Figure 22: North America Pharma-grade Camphor Market Attractiveness Analysis, By Application Figure 23: North America Pharma-grade Camphor Market Attractiveness Analysis, By Distribution Channel Figure 24: Latin America Pharma-grade Camphor Market Value Analysis By Distribution Channel (2021 & 2028) Figure 25: North America Pharma-grade Camphor Market Value Share Analysis, by Application (2021) Figure 26: Latin America Pharma-grade Camphor Market Volume Share (%), By Country (2022 & 2028) Figure 27: Latin America Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021, Figure 28: Latin America Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 29: Brazil Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 30: Brazil Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 31: Mexico Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 32: Mexico Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 33: Argentina Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 34: Argentina Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 35: Rest of Latin America Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 36: Rest of Latin America Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 37: Latin America Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021, By Conventional B2B Figure 38: Latin America Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Conventional B2B Figure 39: Latin America Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021, By Online B2B Figure 40: Latin America Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Online B2B Figure 41: Latin America Pharma-grade Camphor Market Attractiveness Analysis, By Country Figure 42: Latin America Pharma-grade Camphor Market Attractiveness Analysis, By Formulation Figure 43: Latin America Pharma-grade Camphor Market Attractiveness Analysis, By Application Figure 44: Latin America Pharma-grade Camphor Market Attractiveness Analysis, By Distribution Channel Figure 45: Western Europe Pharma-grade Camphor Market Value Analysis By Distribution Channel (2021 & 2028) Figure 46: Western Europe Pharma-grade Camphor Market Value Share Analysis, by Application (2021) Figure 47: Western Europe Pharma-grade Camphor Market Volume Share (%), By Country (2022 & 2028) Figure 48: Western Europe Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 49: Western Europe Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 50: Germany Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 51: Germany Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 52: France Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 53: France Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 54: U.K. Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 55: U.K. Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 56: Spain Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 57: Spain Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 58: Italy Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 59: Italy Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 60: Rest of Western Europe Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 61: Rest of Western Europe Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 62: Western Europe Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021, By Conventional B2B Figure 63: Western Europe Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Conventional B2B Figure 64: Western Europe Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021, By Online B2B Figure 65: Western Europe Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Online B2B Figure 66: Western Europe Pharma-grade Camphor Market Attractiveness Analysis, By Country Figure 67: Western Europe Pharma-grade Camphor Market Attractiveness Analysis, By Formulation Figure 68: Western Europe Pharma-grade Camphor Market Attractiveness Analysis, By Application Figure 69: Western Europe Pharma-grade Camphor Market Attractiveness Analysis, By Distribution Channel Figure 70: Eastern Europe Pharma-grade Camphor Market Value Analysis By Distribution Channel (2021 & 2028) Figure 71: Eastern Europe Pharma-grade Camphor Market Value Share Analysis, by Application (2021) Figure 72: Eastern Europe Pharma-grade Camphor Market Volume Share (%), By Country (2022 & 2028) Figure 73: Eastern Europe Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 74: Eastern Europe Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 75: Russia Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 76: Russia Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 77: Poland Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 78: Poland Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 79: Rest of Eastern Europe Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021, By Country Figure 80: Rest of Eastern Europe Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 81: Eastern Europe Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021, By Conventional B2B Figure 82: Eastern Europe Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Conventional B2B Figure 83: Eastern Europe Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021, By Online B2B Figure 84: Eastern Europe Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Online B2B Figure 85: Eastern Europe Pharma-grade Camphor Market Attractiveness Analysis, By Country Figure 86: Eastern Europe Pharma-grade Camphor Market Attractiveness Analysis, By Formulation Figure 87: Eastern Europe Pharma-grade Camphor Market Attractiveness Analysis, By Application Figure 88: Eastern Europe Pharma-grade Camphor Market Attractiveness Analysis, By Distribution Channel Figure 89: APECJ Pharma-grade Camphor Market Value Analysis By Distribution Channel (2021 & 2028) Figure 90: APECJ Pharma-grade Camphor Market Value Share Analysis, by Application (2021) Figure 91: APECJ Pharma-grade Camphor Market Volume Share (%), By Country (2022 & 2028) Figure 92: APECJ Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 93: APECJ Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 94: Australia & New Zealand Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 95: Australia & New Zealand Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 96: India Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 97: India Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 98: ASEAN Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021, By Country Figure 99: ASEAN Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 100: Rest of APECJ Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 101: Rest of APECJ Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 102: APECJ Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021, By Conventional B2B Figure 103: APECJ Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Conventional B2B Figure 104: APECJ Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021, By Online B2B Figure105: APECJ Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Online B2B Figure 106: APECJ Pharma-grade Camphor Market Attractiveness Analysis, By Country Figure 107: APECJ Pharma-grade Camphor Market Attractiveness Analysis, By Formulation Figure 108: APECJ Pharma-grade Camphor Market Attractiveness Analysis, By Application Figure 109: APECJ Pharma-grade Camphor Market Attractiveness Analysis, By Distribution Channel Figure 110: Japan Pharma-grade Camphor Market Value Analysis By Distribution Channel (2021 & 2028) Figure 111: Japan Pharma-grade Camphor Market Value Share Analysis, by Application (2021) Figure 112: Japan Pharma-grade Camphor Market Volume Share (%) (2022 & 2028) Figure 113: Japan Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 114: Japan Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 115: Japan Pharma-grade Camphor Market Volume (MT) Analysis, 2013-2021 Figure 116: Japan Pharma-grade Camphor Market Volume (MT) & Y-o-Y Growth (%), 2022-2028 Figure 117: Japan Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021, By Conventional B2B Figure 118: Japan Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Conventional B2B Figure 119: Japan Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021, By Online B2B Figure 120: Japan Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Online B2B Figure 121: Japan Pharma-grade Camphor Market Attractiveness Analysis, By Application Figure 122: Japan Pharma-grade Camphor Market Attractiveness Analysis, By Formulation Figure 123: Japan Pharma-grade Camphor Market Attractiveness Analysis, By Distribution Channel Figure 124: China Pharma-grade Camphor Market Value Analysis By Distribution Channel (2021& 2028) Figure 125: China Pharma-grade Camphor Market Value Share Analysis, by Application (2021) Figure 126: China Pharma-grade Camphor Market Volume Share (%) (2022 & 2028) Figure 127: China Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 128: China Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 129: China Pharma-grade Camphor Market Volume (MT) Analysis, 2013-2021 Figure 130: China Pharma-grade Camphor Market Volume (MT) & Y-o-Y Growth (%), 2022-2028 Figure 131: China Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021, By Conventional B2B Figure 132: China Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Conventional B2B Figure 133: China Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021, By Online B2B Figure 134: China Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Online B2B Figure 135: China Pharma-grade Camphor Market Attractiveness Analysis, By Application Figure 136: China Pharma-grade Camphor Market Attractiveness Analysis, By Formulation Figure 137: China Pharma-grade Camphor Market Attractiveness Analysis, By Distribution Channel Figure 138: MEA Pharma-grade Camphor Market Value Analysis By Distribution Channel (2021 & 2028) Figure 139: MEA Pharma-grade Camphor Market Value Share Analysis, by Application (2021) Figure 140: MEA Pharma-grade Camphor Market Volume Share (%), By Country (2022 & 2028) Figure 141: MEA Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021, Figure 142: MEA Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 143: GCC Countries Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 144: GCC Countries Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 145: South Africa Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 146: South Africa Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 147: Rest of MEA Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021 Figure 148: Rest of MEA Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 149: MEA Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021, By Conventional B2B Figure 150: MEA Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Conventional B2B Figure 151: MEA Pharma-grade Camphor Market Size (US$ Mn) Analysis, 2013-2021, By Online B2B Figure 152: MEA Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Online B2B Figure 153: MEA Pharma-grade Camphor Market Attractiveness Analysis, By Country Figure 154: MEA Pharma-grade Camphor Market Attractiveness Analysis, By Formulation Figure 155: MEA Pharma-grade Camphor Market Attractiveness Analysis, By Application Figure 156: MEA Pharma-grade Camphor Market Attractiveness Analysis, By Distribution Channel Figure 157: Global Pharma-grade Camphor Market Attractiveness Analysis, By Region Figure 158: Global Pharma-grade Camphor Market Attractiveness Analysis, By Formulation Figure 159: Global Pharma-grade Camphor Market Attractiveness Analysis, By Application Figure 160: Global Pharma-grade Camphor Market Attractiveness Analysis, By Distribution Channel Figure 161: Global Single-Photon Emission Computed Tomography Historical Market Size and Y-o-Y, 2012 - 2016 Figure 162: Global Pharma-grade Camphor Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 163: Global Pharma-grade Camphor Market Absolute $ Opportunity, 2012–2027
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
